Clinical Trials
3 trialsNCT01375140 2025-06-08
Ruxolitinib and Lenalidomide for Patients With Myelofibrosis
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00946270 2019-06-10
Pomalidomide for Myelofibrosis Patients
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00445900 2011-03-17
Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia
Mayo Clinic
Phase 2 Completed